Insider Buying: OptiBiotix Health (LON:OPTI) Insider Acquires £987,622.75 in Stock

OptiBiotix Health Plc (LON:OPTI) insider David Blain purchased 84,053 shares of the stock in a transaction on Wednesday, October 1st. The stock was acquired at an average cost of GBX 1,175 per share, with a total value of £987,622.75.

OptiBiotix Health Trading Down 4.1%

Shares of LON OPTI opened at GBX 10.55 on Friday. The stock has a market cap of £10.90 million, a price-to-earnings ratio of -573.48 and a beta of 1.71. OptiBiotix Health Plc has a 12 month low of GBX 9 and a 12 month high of GBX 23.50. The company has a 50 day simple moving average of GBX 10.95 and a two-hundred day simple moving average of GBX 13.53.

OptiBiotix Health (LON:OPTI) last announced its earnings results on Tuesday, September 16th. The company reported GBX (1.15) EPS for the quarter. OptiBiotix Health had a negative net margin of 524.43% and a negative return on equity of 36.76%.

About OptiBiotix Health

OptiBiotix Health plc (AIM: OPTI), which was formed in March 2012, brings science to the development of compounds which modify the human microbiome – the collective genome of the microbes in the body – in order to prevent and manage human disease and promote wellness.

OptiBiotix has an extensive R&D programme working with leading academics in the development of microbial strains, compounds, and formulations which are used as active ingredients and supplements.